Cargando…
The Leading Concerns of American Women with Nausea and Vomiting of Pregnancy Calling Motherisk NVP Helpline
Background. Nausea and vomiting of pregnancy (NVP) is the most common medical condition of pregnancy, affecting up to 85% of expecting mothers. In the USA, there is no FDA-approved medication for the treatment of NVP. Objective. To identify the primary concerns of American women leading them to cont...
Autores principales: | Madjunkova, Svetlana, Maltepe, Caroline, Koren, Gideon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649700/ https://www.ncbi.nlm.nih.gov/pubmed/23690784 http://dx.doi.org/10.1155/2013/752980 |
Ejemplares similares
-
The Delayed-Release Combination of Doxylamine and Pyridoxine (Diclegis(®)/Diclectin(®)) for the Treatment of Nausea and Vomiting of Pregnancy
por: Madjunkova, Svetlana, et al.
Publicado: (2014) -
Discordance between physical symptoms versus perception of severity by women with nausea and vomiting in pregnancy (NVP)
por: Chandra, Kiran, et al.
Publicado: (2002) -
Preemptive Treatment of Nausea and Vomiting of Pregnancy: Results of a Randomized Controlled Trial
por: Maltepe, Caroline, et al.
Publicado: (2013) -
The Effect of Acid-Reducing Pharmacotherapy on the Severity of Nausea and Vomiting of Pregnancy
por: Gill, Simerpal Kaur, et al.
Publicado: (2009) -
Nausea and vomiting of pregnancy and resource implications: the NVP Impact Study
por: Gadsby, Roger, et al.
Publicado: (2019)